Market Overview:
The global radiation toxicity market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cancer, rising awareness about radiation toxicity treatments, and technological advancements in the field of radiation therapy. The global radiation toxicity market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into blood transfusion, antibiotic treatment, and others (including supportive care measures such as nutritional support). The blood transfusion segment is expected to account for the largest share of the global radiation toxicity market in 2018. This can be attributed to factors such as growing incidence of cancer and rising awareness about blood transfusions as a treatment for radiation sickness.
 Industry Outlook.svg)
Product Definition:
Radiation toxicity refers to the harmful effects of radiation on living tissue. Acute radiation syndrome (ARS) is a condition that can occur after exposure to a large dose of ionizing radiation. Symptoms may include nausea, vomiting, diarrhea, fever, and weakness. If not treated, ARS can lead to death. The importance of radiation toxicity is that it can cause serious harm to the body if not properly treated.
Blood Transfusion:
Blood transfusion is the process of replacing blood loss from a patient. It is done during surgeries or when a person has been injured and can’t produce enough blood on their own. The most common reason for blood transfusion is surgery, trauma, or medical emergency.
Factors that propel the growth of this market include rising prevalence of chronic diseases such as cancer & anemia, increasing geriatric population base.
Antibiotic:
Antibiotics are drugs used to treat bacterial infections. Bacterial infection includes many types of infections such as pneumonia, earaches, and skin diseases. Antibiotics can be administered in two ways: In acute care (short term) or in chronic care (long term). The most common antibiotics used today are penicillin, tetracycline and cephalosporin.
Application Insights:
The hospital segment dominated the global market in 2017 and is expected to continue its dominance over the forecast period. The growing number of hospitals, increase in patient admissions, and an increase in cancer cases are some of the factors contributing to the growth of this segment. Moreover, a rise in travel activities due to various health issues is also driving this segment. According to WHO Global Health Observatory (GHO), around 1% - 2% people die every year due to radiation exposure while receiving medical treatment. This has ledto increased focus on minimizing radiation exposure while providing high-quality healthcare services at a reasonable cost for patients across various countries worldwide including U.S., China, Japan etc.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of nuclear reactors and research centers that irradiate patients with high doses of ionizing radiation is one major factor responsible for its dominance. Moreover, the stringent regulatory framework established by the U.S.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to increasing cases of cancer due to chronic exposure (over decades)to low dose radiation in countries, such as Japan, China, and India.
Infectious diseases are amongthe leading causesof mortalityand morbidityin developing regions including Asia Pacific.
Growth Factors:
- Increasing incidence of cancer: The increasing incidence of cancer is the major growth driver for radiation toxicity market. According to World Health Organization (WHO), in 2012, there were 14 million new cases of cancer and 8.2 million deaths from the disease worldwide. This number is expected to increase to 21 million new cases and 13 million deaths by 2030. This will lead to an increased demand for radiation therapy, which in turn will result in an increased incidence of radiation toxicity
- Rising awareness about radiation therapy: There is a rising awareness among people about the benefits of radiation therapy over other treatment options such as surgery and chemotherapy. This is driving people towards seeking radiotherapy as a treatment option, thereby leading to an increase in demand for radiotherapy services and subsequently, an increase in incidence of radiation toxicity
- Technological advancements: The technological advancements taking place within the field of radiotherapy are helping healthcare professionals treat cancers with higher precision levels than ever before, thus minimizing collateral damage caused by irradiation on healthy tissues surrounding the tumor site Consequently this is resulting in reduced side effects associated with radiotherapy treatments including Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) thereby leading to its growing adoption rates amongst patients diagnosed with cancerous tumors
Scope Of The Report
Report Attributes
Report Details
Report Title
Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Research Report
By Type
Blood Transfusion, Antibiotic, Others
By Application
Hospital, Clinic
By Companies
Aeolus Pharmaceuticals, Inc., Atox Bio Ltd, BCN Biosciences LLC, Cellphire Inc, Daiichi Sankyo Co Ltd, FirstString Research Inc, RxBio Inc, Shuttle Pharmaceuticals LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Report Segments:
The global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) market is segmented on the basis of:
Types
Blood Transfusion, Antibiotic, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Aeolus Pharmaceuticals, Inc.
- Atox Bio Ltd
- BCN Biosciences LLC
- Cellphire Inc
- Daiichi Sankyo Co Ltd
- FirstString Research Inc
- RxBio Inc
- Shuttle Pharmaceuticals LLC
 Market Overview.svg)
Highlights of The Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood Transfusion
- Antibiotic
- Others
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radiation toxicity is a medical condition caused by exposure to radiation. Radiation sickness is the most common form of radiation toxicity, and it can occur after any exposure to radiation, including natural background radiation and cancer treatments. Acute Radiation Syndrome (ARS) is a serious health condition that can develop after high doses of ionizing radiation therapy or other forms of radiotherapy.
Some of the major companies in the radiation toxicity (radiation sickness, acute radiation syndrome) market are Aeolus Pharmaceuticals, Inc., Atox Bio Ltd, BCN Biosciences LLC, Cellphire Inc, Daiichi Sankyo Co Ltd, FirstString Research Inc, RxBio Inc, Shuttle Pharmaceuticals LLC.
The radiation toxicity (radiation sickness, acute radiation syndrome) market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size & Forecast, 2018-2028
4.5.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size and Y-o-Y Growth
4.5.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Absolute $ Opportunity
Chapter 5 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Type
5.2.1 Blood Transfusion
5.2.2 Antibiotic
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Analysis and Forecast
9.1 Introduction
9.2 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Type
9.6.1 Blood Transfusion
9.6.2 Antibiotic
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Analysis and Forecast
10.1 Introduction
10.2 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Type
10.6.1 Blood Transfusion
10.6.2 Antibiotic
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Type
11.6.1 Blood Transfusion
11.6.2 Antibiotic
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Analysis and Forecast
12.1 Introduction
12.2 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Type
12.6.1 Blood Transfusion
12.6.2 Antibiotic
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Type
13.6.1 Blood Transfusion
13.6.2 Antibiotic
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market: Competitive Dashboard
14.2 Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Aeolus Pharmaceuticals, Inc.
14.3.2 Atox Bio Ltd
14.3.3 BCN Biosciences LLC
14.3.4 Cellphire Inc
14.3.5 Daiichi Sankyo Co Ltd
14.3.6 FirstString Research Inc
14.3.7 RxBio Inc
14.3.8 Shuttle Pharmaceuticals LLC
